Association of CYP24A1 Gene rs6127099 (A > T) Polymorphism with Lower Risk to COVID-19 Infection in Kazakhstan

Genes (Basel). 2023 Jan 24;14(2):307. doi: 10.3390/genes14020307.

Abstract

In December 2019, SARS-CoV-2 was identified in Wuhan, China. Infection by SARS-CoV-2 causes coronavirus disease 2019 (COVID-19), which is characterized by fever, cough, dyspnea, anosmia, and myalgia in many cases. There are discussions about the association of vitamin D levels with COVID-19 severity. However, views are conflicting. The aim of the study was to examine associations of vitamin D metabolism pathway gene polymorphisms with symptomless COVID-19 susceptibility in Kazakhstan. The case-control study examined the association between asymptomatic COVID-19 and vitamin D metabolism pathway gene polymorphisms in 185 participants, who previously reported not having COVID-19, were PCR negative at the moment of data collection, and were not vaccinated. A dominant mutation in rs6127099 (CYP24A1) was found to be protective of asymptomatic COVID-19. Additionally, the G allele of rs731236 TaqI (VDR), dominant mutation in rs10877012 (CYP27B1), recessive rs1544410 BsmI (VDR), and rs7041 (GC) are worth consideration since they were statistically significant in bivariate analysis, although their independent effect was not found in the adjusted multivariate logistic regression model.

Keywords: COVID-19; SARS-CoV-2; immune system; metabolism; vitamin D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / genetics
  • Case-Control Studies
  • Genetic Predisposition to Disease*
  • Humans
  • Kazakhstan
  • Polymorphism, Single Nucleotide
  • Receptors, Calcitriol / genetics
  • SARS-CoV-2
  • Vitamin D
  • Vitamin D3 24-Hydroxylase* / genetics

Substances

  • CYP24A1 protein, human
  • Receptors, Calcitriol
  • Vitamin D
  • Vitamin D3 24-Hydroxylase

Grants and funding

This research was funded by Nazarbayev University, grant number 021220CRP0822.